Molecular Metabolism·Nov 4Discovery, optimization, and Phase 1 evaluation of a novel, orally available GLP-1R/GIPR dual agonistNon-randomized trial in peopleGLP-1 receptor agonistsPaper
Pharmaceutics·Nov 2A Novel Salcaprozate Sodium Deep Eutectic System for Oral Semaglutide Delivery and Enhanced Skin PenetrationExperiments in miceSemaglutidePaper
Journal of Controlled Release·Feb 12Gut microbiota perturbation and systemic inflammation are associated with salcaprozate sodium (SNAC)-enabled oral semaglutide deliveryExperiments in ratsSemaglutidePaper
International Journal of Clinical Pharmacology and Therapeutics·Jan 26Hemoglobin A1c levels in patients with type 2 diabetes mellitus receiving oral semaglutide with versus without proton pump inhibitors: An exploratory studyCohort study of 66 peopleProton-pump inhibitorsPaper